Glioblastoma under Siege: An Overview of Current Therapeutic Strategies

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · see citing works

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405 · see citing works

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works

The Somatic Genomic Landscape of Glioblastoma

Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016 · see citing works

Structural and functional features of central nervous system lymphatic vessels

Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413 · see citing works

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Hamid, O., Robert, C., DAUD, A. I., Hodi, F. S., Hwu, W., Kefford, R. F., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305133 · Cited by 3,373 · see citing works

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma

Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,178 · see citing works

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Brown, C. E., Alizadeh, D., Starr, R., Weng, L., Wagner, J. R., Naranjo, A., Ostberg, J. R., Blanchard, M. S., Kilpatrick, J., Simpson, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610497 · Cited by 1,842 · see citing works

Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma

Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828 · see citing works

The cellular and molecular basis of hyperthermia

Hildebrandt, B. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00179-2 · Cited by 1,714 · see citing works

Glioblastoma: Overview of Disease and Treatment

Davis, M. E. (2016) · Clinical journal of oncology nursing · doi:10.1188/16.cjon.s1.2-8 · Cited by 1,222 · see citing works

Temozolomide resistance in glioblastoma multiforme

Lee, S. Y. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.04.007 · Cited by 1,173 · see citing works

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Weller, M., Butowski, N. A., Tran, D. D., Recht, L. D., Lim, M. K., Hirte, H. W., Ashby, L. S., Mechtler, L. L., Goldlust, S. A., IWAMOTO, F. M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30517-x · Cited by 1,138 · see citing works

Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma

Bhat, K., Balasubramaniyan, V., Vaillant, B. D., Ezhilarasan, R., Hummelink, K., Hollingsworth, F., Wani, K., Heathcock, L. E., James, J. D., Goodman, L. D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.001 · Cited by 1,110 · see citing works

Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma

Darmanis, S., Sloan, S. A., Croote, D., Mignardi, M., Chernikova, S. B., Samghababi, P., Zhang, Y., Neff, N. F., Kowarsky, M., Caneda, C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.030 · Cited by 1,004 · see citing works

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

Venteicher, A. S., Tirosh, I., Hebert, C. M., Yizhak, K., Neftel, C., Filbin, M. G., Hovestadt, V., Escalante, L. E., Shaw, M. L., Rodman, C., et al. (2017) · Science · doi:10.1126/science.aai8478 · Cited by 975 · see citing works

Advances in the molecular genetics of gliomas — implications for classification and therapy

Reifenberger, G., Wirsching, H.-G., Knobbe-Thomsen, C. B., & Weller, M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.204 · Cited by 662 · see citing works

Potential of solid lipid nanoparticles in brain targeting.

Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615 · see citing works

Recent progress in the battle between oncolytic viruses and tumours

Parato, K. A., Senger, D. L., Forsyth, P. A., & Bell, J. C. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1750 · Cited by 538 · see citing works

Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells

Chen, J., McKay, R. M., & Parada, L. F. (2012) · Cell · doi:10.1016/j.cell.2012.03.009 · Cited by 526 · see citing works

Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

Roos, W. P., Batista, L. F. Z., Naumann, S. C., Wick, W., Weller, M., Menck, C. F. M., & Kaina, B. (2006) · Oncogene · doi:10.1038/sj.onc.1209785 · Cited by 499 · see citing works

Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma

Brown, C. E., Aguilar, B., Starr, R., Yang, X., Chang, W.-C., Weng, L., Chang, B., Sarkissian, A., Brito, A., Sanchez, J. F., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.10.002 · Cited by 301 · see citing works

Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma

Neyns, B., Sadones, J., Joosens, E. J., Bouttens, F., Verbeke, L., Baurain, J., D'Hondt, L. A., Strauven, T., Chaskis, C., Veld, P. I. '., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp032 · Cited by 250 · see citing works

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma

Padfield, E., Ellis, H. P., & Kurian, K. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00005 · Cited by 244 · see citing works

Oncolytic Virus Therapy for Glioblastoma Multiforme

Wollmann, G., Özduman, K., & van den Pol, A. N. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31824671c9 · Cited by 206 · see citing works

Diffuse Infiltrating Oligodendroglioma and Astrocytoma

van den Bent, M. J., Smits, M., Kros, J. M., & Chang, S. M. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.6737 · Cited by 175 · see citing works

Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy

Xue, S., Hu, M., Iyer, V. R., & Yu, J. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0455-6 · Cited by 169 · see citing works

In Vivo Specific Delivery of c-Met siRNA to Glioblastoma Using Cationic Solid Lipid Nanoparticles

Jin, J., Bae, K. H., Yang, H., Lee, S. J., Kim, H., Kim, Y., Joo, K. M., Seo, S. W., Park, T. G., & Nam, D. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200406n · Cited by 149 · see citing works

Integrins and Exosomes, a Dangerous Liaison in Cancer Progression

Paolillo, M., & Schinelli, S. (2017) · Cancers · doi:10.3390/cancers9080095 · Cited by 130 · see citing works

Nanoparticles: Novel vehicles in treatment of Glioblastoma

Pourgholi, F., Hajivalili, M., Jadidi‐Niaragh, F., Kafil, H. S., & Yousefi, M. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.014 · Cited by 120 · see citing works

Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells

Gan, H. K., van den Bent, M. J., Lassman, A. B., Reardon, D. A., & Scott, A. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.95 · Cited by 118 · see citing works

Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case–control study

Park, K.-J., Kano, H., Iyer, A., Liu, X., Niranjan, A., Flíckinger, J. C., Lieberman, F. S., Lunsford, L. D., & Kondziolka, D. S. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0744-9 · Cited by 109 · see citing works

Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles

Zhang, F., Huang, X., Zhu, L., Guo, N., Niu, G., Swierczewska, M., Lee, S., Xu, H. T., Wang, A. Y., Mohamedali, K. A., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.032 · Cited by 107 · see citing works

Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis

Carlo, D. T. D., Cagnazzo, F., Benedetto, N., Morganti, R., & Perrini, P. (2017) · Neurosurgical Review · doi:10.1007/s10143-017-0928-7 · Cited by 105 · see citing works

Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy

Vitucci, M., Hayes, D. N., & Miller, C. R. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606031 · Cited by 101 · see citing works

Relationship between expression of PD-L1 and tumor angiogenesis, proliferation, and invasion in glioma

Xue, S., Hu, M., Li, P., Ma, J., Xie, L., Teng, F., Zhu, Y., Fan, B., Mu, D., & Yu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17922 · Cited by 97 · see citing works

Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16

Aghi, M. K., Visted, T., DePinho, R. A., & Chiocca, E. A. (2008) · Oncogene · doi:10.1038/onc.2008.53 · Cited by 94 · see citing works

Adenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma

Ji, N., Weng, D., Liu, C., Gu, Z., Chen, S., Guo, Y., Fan, Z., Wang, X., Chen, J., Zhao, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6737 · Cited by 91 · see citing works

Multifunctional targeted liposomal drug delivery for efficient glioblastoma treatment

Belhadj, Z., Zhan, C., Man, Y. M., Wei, X., Xie, C., Yan, Z., & Lu, W. (2017) · Oncotarget · doi:10.18632/oncotarget.17976 · Cited by 91 · see citing works

Integrins in glioblastoma: Still an attractive target?

Paolillo, M., Serra, M., & Schinelli, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.004 · Cited by 90 · see citing works

Immunotherapy for the Treatment of Glioblastoma

Thomas, A. A., Ernstoff, M. S., & Fadul, C. E. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182431a73 · Cited by 90 · see citing works

Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model

Mitchell, L., Espinoza, F. L., Mendoza, D., Kato, Y., Inagaki, A., Hiraoka, K., Kasahara, N., Gruber, H. E., Jolly, D. J., & Robbins, J. M. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox037 · Cited by 86 · see citing works

Glioma virus therapies between bench and bedside

Kaufmann, J. K., & Chiocca, E. A. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not310 · Cited by 79 · see citing works

Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model

Kawaguchi, K., Igarashi, K., Li, S., Han, Q., Tan, Y., Kiyuna, T., Miyake, K., Murakami, T., Chmielowski, B., Nelson, S. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20231 · Cited by 72 · see citing works

History and current state of immunotherapy in glioma and brain metastasis

McGranahan, T. M., Li, G., & Nagpal, S. (2017) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017693750 · Cited by 68 · see citing works

Targeted Delivery of Tumor Suppressor microRNA-1 by Transferrin- Conjugated Lipopolyplex Nanoparticles to Patient-Derived Glioblastoma Stem Cells

Wang, X., Huang, X., Yang, Z., Gallego‐Perez, D., Ma, J., Zhao, X., Xie, J., Nakano, I., & Lee, L. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666141031105234 · Cited by 65 · see citing works

Depletion of O6-methylguanine-DNA methyltransferase by O6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines

Murakami, J., Lee, Y., Kokeguchi, S., Tsujigiwa, H., Asaumi, J., Nagatsuka, H., Fukui, K., Kuroda, M., Tanaka, N., & Matsubara, N. (2007) · Oncology Reports · doi:10.3892/or.17.6.1461 · Cited by 63 · see citing works

Extended field stereotactic radiosurgery for recurrent glioblastoma

Koga, T., Maruyama, K., Tanaka, M., Ino, Y., Saito, N., Nakagawa, K., Shibahara, J., & Todo, T. (2011) · Cancer · doi:10.1002/cncr.27372 · Cited by 62 · see citing works

Effective treatment of neuroendocrine tumors With temozolomide and capecitabine

Fine, R. L., Fogelman, D. R., & Schreibman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.4216 · Cited by 60 · see citing works

Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients

Tejada, S., Alonso, M. M., Patiño‐García, A., Fueyo-Margareto, J., Gomez‐Manzano, C., & Díez-Valle, R. (2017) · Neurosurgery · doi:10.1093/neuros/nyx507 · Cited by 55 · see citing works

Clinical outcomes following salvage gamma knife radiosurgery for recurrent glioblastoma

Larson, E. W. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i2.142 · Cited by 49 · see citing works

Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response

Owen, D. H., Alexander, A. J., Konda, B., Wei, L., Hemminger, J. A., Schmidt, C. R., Abdel‐Misih, S., Dillhoff, M. E., Sipos, J. A., Kirschner, L. S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22001 · Cited by 42 · see citing works

Basic concepts of immunology and neuroimmunology

Sehgal, A., & Berger, M. S. (2000) · Neurosurgical FOCUS · doi:10.3171/foc.2000.9.6.2 · Cited by 38 · see citing works

First-Line Monotherapy With Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Advanced Non-Small Cell Lung Cancer (NSCLC): Safety, Efficacy, and Correlation of Outcomes With PD-L1 Status

Rizvi, N. A., Shepherd, F. A., Antonia, S. J., Brahmer, J. R., Chow, L. Q. M., Goldman, J. W., Juergens, R. A., Borghaei, H., Ready, N., Gerber, D. E., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.08.204 · Cited by 37 · see citing works

IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA

Reardon, D. A., Desjardins, A., Schuster, J. M., Tran, D. D., Fink, K., Nabors, B., Li, G., Bota, D. A., Lukas, R. V., Ashby, L. S., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov218.08 · Cited by 30 · see citing works

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors

Saif, M. W., Kotteas, E. A., & Syrigos, K. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s72155 · Cited by 29 · see citing works

Abstract CT027: Oncolytic virus DNX-2401 with a short course of temozolomide for glioblastoma at first recurrence: Clinical data and prognostic biomarkers

Alonso, M. M., García-Moure, M., González-Huarriz, M., Marigil, M., Hernández-Alcoceba, R., Buñales, M., Hervás, S., Pérez‐Larraya, J. G., Gomez‐Manzano, C., Fueyo-Margareto, J., et al. (2017) · Cancer Research · doi:10.1158/1538-7445.am2017-ct027 · Cited by 27 · see citing works

Novel Vaccines for Glioblastoma: Clinical Update and Perspective

Winograd, E. K., Ciesielski, M. J., & Fenstermaker, R. A. (2016) · Immunotherapy · doi:10.2217/imt-2016-0059 · Cited by 26 · see citing works

Impact of somatic copy number alterations on the glioblastoma mi RN ome: miR‐4484 is a genomically deleted tumour suppressor

Nawaz, Z., Patil, V., Thinagararjan, S., Rao, S. A. M., Hegde, A. S., Arivazhagan, A., Santosh, V., & Somasundaram, K. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12060 · Cited by 25 · see citing works

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme

Hernández‐Pedro, N., Rangel‐López, E., Félix, G. V., Pineda, B., & Sotelo, J. (2013) · Autoimmune Diseases · doi:10.1155/2013/716813 · Cited by 22 · see citing works

Functional network analysis of gene-phenotype connectivity associated with temozolomide

Shi, J. H., Dong, B., Zhou, P., Guan, W., & Peng, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.20848 · Cited by 16 · see citing works

Rindopepimut Vaccine and Bevacizumab Combination Therapy: Improving Survival Rates in Relapsed Glioblastoma Patients?

Neagu, M. R., & Reardon, D. A. (2015) · Immunotherapy · doi:10.2217/imt.15.39 · Cited by 15 · see citing works

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors

Kotteas, E. A., Syrigos, K., & Saif, M. W. (2016) · Dove Medical Press (Taylor and Francis Group) · Cited by 13 · see citing works

CAR T cells in glioblastoma

Sarah, C. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.158 · Cited by 5 · see citing works

A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity

Jacob, F., Salinas, R. D., Zhang, D. Y., Nguyen, P. T. T., Schnoll, J. G., Wong, S. Z. H., Thokala, R., Sheikh, S., Saxena, D., Prokop, S., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.036 · Cited by 1,149 · see citing works

Combination therapy to checkmate Glioblastoma: clinical challenges and advances

Ghosh, D., Nandi, S., & Bhattacharjee, S. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0211-8 · Cited by 228 · see citing works

AGuIX ® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine

Lux, F., Tran, V. L., Thomas, E., Dufort, S., Rossetti, F., Martini, M., Truillet, C., Doussineau, T., Bort, G., Denat, F., et al. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180365 · Cited by 178 · see citing works

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy

Zhang, P., Qin, X., Liu, L., Li, S., & Dong, L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.562798 · Cited by 161 · see citing works

Therapy for glioblastoma: is it working?

Zanders, E. D., Svensson, F., & Bailey, D. S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.008 · Cited by 133 · see citing works

Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma

Monfared, H., Jahangard, Y., Nikkhah, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00782 · Cited by 123 · see citing works

Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials

Bruinsmann, F. A., Vaz, G. R., Alves, A. D. C. S., Aguirre, T. A. S., Pohlmann, A. R., Guterres, S. S., & Sonvico, F. (2019) · Molecules · doi:10.3390/molecules24234312 · Cited by 117 · see citing works

An Interplay between Senescence, Apoptosis and Autophagy in Glioblastoma Multiforme—Role in Pathogenesis and Therapeutic Perspective

Pawłowska, E., Szczepańska, J., Szatkowska, M., & Błasiak, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030889 · Cited by 98 · see citing works

Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors

McEwen, A. E., Leary, S. E. S., & Lockwood, C. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00045 · Cited by 82 · see citing works

Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway

Jiang, Y., Zhou, J., Luo, P., Gao, H., Ma, Y., Chen, Y.-S., Li, L., Zou, D., Zhang, Y., & Jing, Z. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.053 · Cited by 76 · see citing works

In Vitro Glioblastoma Models: A Journey into the Third Dimension

Paolillo, M., Comincini, S., & Schinelli, S. (2021) · Cancers · doi:10.3390/cancers13102449 · Cited by 75 · see citing works

Pathogenetic Features and Current Management of Glioblastoma

Nguyen, H.-M., Guz-Montgomery, K., Lowe, D. B., & Saha, D. (2021) · Cancers · doi:10.3390/cancers13040856 · Cited by 67 · see citing works

Organoid models of glioblastoma: advances, applications and challenges.

Zhang, C., Jin, M.-Z., Zhao, J., Chen, J., & Jin, W. (2020) · PubMed Central · Cited by 64 · see citing works

Targeting Receptors on Cancer Cells with Protein Toxins

Antignani, A., Ho, E. C. H., Bilotta, M. T., Qiu, R., Sarnvosky, R., & FitzGerald, D. J. (2020) · Biomolecules · doi:10.3390/biom10091331 · Cited by 58 · see citing works

Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers

He, L., Zhong, Z., Chen, M., Liang, Q., Wang, Y., & Tan, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.775084 · Cited by 57 · see citing works

Prediction of Core Signaling Pathway by Using Diffusion- and Perfusion-based MRI Radiomics and Next-generation Sequencing in Isocitrate Dehydrogenase Wild-type Glioblastoma

Park, J. E., Kim, H. S., Park, S. Y., Nam, S. J., Chun, S., Jo, Y., & Kim, J. H. (2019) · Radiology · doi:10.1148/radiol.2019190913 · Cited by 56 · see citing works

Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma

Kim, Y., Kang, H., Powathil, G., Kim, H., Trucu, D., Lee, W., Lawler, S. E., & Chaplain, M. A. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204865 · Cited by 50 · see citing works

Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles

Guardia, G. D. A., Corrêa, B., Araujo, P. R. D., Qiao, M., Burns, S., Penalva, L. O. F., & Galante, P. A. F. (2020) · npj Genomic Medicine · doi:10.1038/s41525-019-0108-5 · Cited by 50 · see citing works

The Role of the Ubiquitin Proteasome System in Glioma: Analysis Emphasizing the Main Molecular Players and Therapeutic Strategies Identified in Glioblastoma Multiforme

Maksoud, S. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02339-4 · Cited by 48 · see citing works

Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform

Swellam, M. M., Arab, L. E. E., Al-posttany, A. S., & Said, S. B. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03256-2 · Cited by 48 · see citing works

Evaluation of the Impact of Magnetic Resonance Imaging (MRI) on Gross Tumor Volume (GTV) Definition for Radiation Treatment Planning (RTP) of Inoperable High Grade Gliomas (HGGs)

Sağer, Ö., Dinçoğlan, F., Demiral, S., Gamsız, H., Uysal, B., Özcan, F., Çolak, O., Dırıcan, B., & Beyzadeoğlu, M. (2019) · Concepts in Magnetic Resonance Part A · doi:10.1155/2019/4282754 · Cited by 47 · see citing works

Transferrin-Decorated Niosomes with Integrated InP/ZnS Quantum Dots and Magnetic Iron Oxide Nanoparticles: Dual Targeting and Imaging of Glioma

Seleci, D. A., Maurer, V., Barlas, F. B., Porsiel, J. C., Temel, B., Ceylan, A. E., Tımur, S., Stahl, F., Scheper, T. H., & Garnweitner, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094556 · Cited by 46 · see citing works

U-Net Based Segmentation and Characterization of Gliomas

Kihira, S., Mei, X., Mahmoudi, K., Liu, Z., Dogra, S., Belani, P. B., Tsankova, N. M., Hormigo, A., Fayad, Z. A., Doshi, A. H., et al. (2022) · Cancers · doi:10.3390/cancers14184457 · Cited by 43 · see citing works

Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma

Meteoglu, I., & Erdemir, A. D. (2021) · Process Biochemistry · doi:10.1016/j.procbio.2021.07.015 · Cited by 42 · see citing works

Crosstalk between microglia and patient-derived glioblastoma cells inhibit invasion in a three-dimensional gelatin hydrogel model

Chen, J.-W. E., Lumibao, J. C., Leary, S. E. S., Sarkaria, J. N., Steelman, A. J., Gaskins, H. R., & Harley, B. A. C. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02026-6 · Cited by 42 · see citing works

Next Generation Sequencing and Machine Learning Technologies Are Painting the Epigenetic Portrait of Glioblastoma

Jovčevska, I. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00798 · Cited by 41 · see citing works

Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors

Song, J. B., Kadaba, P., Kravitz, A., Hormigo, A., Friedman, J. S., Belani, P. B., Hadjipanayis, C. G., Ellingson, B. M., & Nael, K. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa066 · Cited by 40 · see citing works

Three-dimensional culture models to study glioblastoma — current trends and future perspectives

Joseph, J. V., Blaavand, M. S., Daubon, T., Kruyt, F. A. E., & Thomsen, M. K. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.08.019 · Cited by 39 · see citing works

Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature

Steponaitis, G., & Tamašauskas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094964 · Cited by 39 · see citing works

The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood–Brain Barrier

Kostka, K., Sokolova, V., El-Taibany, A. A., Kruse, B., Porada, D. A., Wolff, N., Prymak, O., Seeds, M. C., Epple, M., & Atala, A. (2024) · Molecules · doi:10.3390/molecules29112469 · Cited by 37 · see citing works

Sequencing the next generation of glioblastomas

Jovčevska, I. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1462759 · Cited by 37 · see citing works

The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma

Ozyerli‐Goknar, E., Sur‐Erdem, İ., Seker-Polat, F., Cingöz, A., Kayabölen, A., Kahya, Z., Uyulur, F., Gezen, M., Tolay, N., Erman, B., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2107-y · Cited by 37 · see citing works

Lanthanide-Doped SPIONs Bioconjugation with Trastuzumab for Potential Multimodal Anticancer Activity and Magnetic Hyperthermia

Gawęda, W., Osial, M. E., Żuk, M., Pękała, M., Bilewicz, A., & Krysiński, P. (2020) · Nanomaterials · doi:10.3390/nano10020288 · Cited by 35 · see citing works

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs

Zottel, A., Šamec, N., Paska, A. V., & Jovčevska, I. (2020) · Cancers · doi:10.3390/cancers12071842 · Cited by 35 · see citing works

Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells

Ivanov, V. N., Wu, J., Wang, T. J. C., & Hei, T. K. (2019) · Oncotarget · doi:10.18632/oncotarget.26582 · Cited by 32 · see citing works

Rat Glioma Cell-Based Functional Characterization of Anti-Stress and Protein Deaggregation Activities in the Marine Carotenoids, Astaxanthin and Fucoxanthin

Afzal, S., Garg, S., Ishida, Y., Terao, K., Kaul, S. C., & Wadhwa, R. (2019) · Marine Drugs · doi:10.3390/md17030189 · Cited by 32 · see citing works

Antibacterial and Anticancer Activity and Untargeted Secondary Metabolite Profiling of Crude Bacterial Endophyte Extracts from Crinum macowanii Baker Leaves

Sebola, T. E., Uche-Okereafor, N. C., Mekuto, L., Makatini, M. M., Green, E., & Mavumengwana, V. (2020) · International Journal of Microbiology · doi:10.1155/2020/8839490 · Cited by 32 · see citing works

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting

Šamec, N., Jovčevska, I., Stojan, J., Zottel, A., Liović, M., Myers, M. P., Muyldermans, S., Šribar, J., Križaj, I., & Komel, R. (2018) · Oncotarget · doi:10.18632/oncotarget.24629 · Cited by 29 · see citing works

The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies

Maksoud, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02915-2 · Cited by 29 · see citing works

Biomaterial-based in vitro 3D modeling of glioblastoma multiforme

Ahmed, T. (2023) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2023.01.002 · Cited by 28 · see citing works

Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration

Ahmadi‐Zeidabadi, M., Akbarnejad, Z., Esmaeeli, M., Masoumi‐Ardakani, Y., Mohammadipoor‐Ghasemabad, L., & Eskandary, H. (2019) · Electromagnetic Biology and Medicine · doi:10.1080/15368378.2019.1625784 · Cited by 28 · see citing works

A Predictive Clinical-Radiomics Nomogram for Survival Prediction of Glioblastoma Using MRI

Ammari, S., de Chou, R. S., Balleyguier, C., Chouzenoux, É., Touat, M., Quillent, A., Dumont, S., Bockel, S., Garcia, G. C. T. E., Elhaik, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11112043 · Cited by 28 · see citing works

The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition

Wang, H., Yu, J., Wang, X., & Zhang, Y. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.12.005 · Cited by 27 · see citing works

Microbiome as a Target for Cancer Therapy

Suraya, R., Nagano, T., Kobayashi, K., & Nishimura, Y. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735420920721 · Cited by 27 · see citing works

High-pressure oxygen rewires glucose metabolism of patient-derived glioblastoma cells and fuels inflammasome response

Arienti, C., Pignatta, S., Zanoni, M., Zamagni, A., Cortesi, M., Sarnelli, A., Romeo, A., Arpa, D., Longobardi, P., Bartolini, D., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.019 · Cited by 27 · see citing works

Recent Approaches and Success of Liposome-Based Nano Drug Carriers for the Treatment of Brain Tumor

Shaw, T. K., & Paul, P. (2021) · Current Drug Delivery · doi:10.2174/1567201818666211213102308 · Cited by 23 · see citing works

Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen

Kast, R. E., Skuli, N., Sardi, I., Capanni, F., Heßling, M., Fròsina, G., Kast, A., Karpel‐Massler, G., & Halatsch, M. (2018) · Brain Sciences · doi:10.3390/brainsci8120203 · Cited by 23 · see citing works

Bismuth(III) complexes with pyrazineformamide thiosemicarbazones: Investigation on the antimicrobial and cytotoxic effects

Almeida, J. C. L., Amim, R. S., Pessoa, C., Lourenço, M. C. S., Mendes, I. C., & Lessa, J. A. (2020) · Polyhedron · doi:10.1016/j.poly.2020.114709 · Cited by 22 · see citing works

SB365, Pulsatilla Saponin D Induces Caspase-Independent Cell Death and Augments the Anticancer Effect of Temozolomide in Glioblastoma Multiforme Cells

Hong, J.-M., Kim, J. H., Kim, H. M., Lee, W. J., & Hwang, Y. (2019) · Molecules · doi:10.3390/molecules24183230 · Cited by 21 · see citing works

Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples

Mukherjee, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-67753-5 · Cited by 18 · see citing works

NF-κB Inhibitor Myrislignan Induces Ferroptosis of Glioblastoma Cells via Regulating Epithelial-Mesenchymal Transformation in a Slug-Dependent Manner

Zhou, Y., Qian, W., Li, X., & Wei, W.-Z. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/7098313 · Cited by 20 · see citing works

Glioma Stem Cells—Features for New Therapy Design

Pećina‐Šlaus, N., & Hrašćan, R. (2024) · Cancers · doi:10.3390/cancers16081557 · Cited by 17 · see citing works

Expression of the First Recombinant Anti-Tumoral Snake Venom Kunitz-Type Serine Protease Inhibitor

Morjen, M., Moslah, W., Touihri-Barakati, I., Srairi‐Abid, N., Luis, J., Marrakchi, N., & Jebali, J. (2022) · Toxins · doi:10.3390/toxins14030170 · Cited by 17 · see citing works

A comprehensive review on lipid nanocarrier systems for cancer treatment: fabrication, future prospects and clinical trials

Kabil, M. F., Badary, O. A., Bier, F. F., Mousa, S. A., & El-sherbiny, I. M. (2023) · Journal of Liposome Research · doi:10.1080/08982104.2023.2204372 · Cited by 17 · see citing works

Doxorubicin-Loaded Ultrasmall Gold Nanoparticles (1.5 nm) for Brain Tumor Therapy and Assessment of Their Biodistribution

Kruse, B., Dash, B. S., Kostka, K., Wolff, N., Prymak, O., Loza, K., Gumbiowski, N., Heggen, M., Oliveira, C. L. P., Chen, J., et al. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00999 · Cited by 17 · see citing works

Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

Ammari, S., de Chou, R. S., Assi, T., Touat, M., Chouzenoux, É., Quillent, A., Limkin, E. J., Dercle, L., Hadchiti, J., Elhaik, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11071263 · Cited by 17 · see citing works

Trends in glioblastoma treatment research: an analysis of clinical trials and literature

Łaba, A., & Ziolkowski, P. P. (2021) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2021.0024 · Cited by 16 · see citing works

Collective invasion of glioma cells through OCT1 signalling and interaction with reactive astrocytes after surgery

Kim, Y., Lee, D., & Lawler, S. E. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0390 · Cited by 16 · see citing works

Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine

Cai, J., Hosmane, N. S., Takagaki, M., & Zhu, Y. (2020) · Molecules · doi:10.3390/molecules25204697 · Cited by 15 · see citing works

The KDR (VEGFR-2) Genetic Polymorphism Q472H and c-KIT Polymorphism M541L Are Associated With More Aggressive Behaviour in Astrocytic Gliomas

ZAMAN, N., DASS, S. S., Parcq, P. D., MacMahon, S., Gallagher, L., THOMPSON, L. A., Khorashad, J. S., & Limbӓck-Stanic, C. (2020) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20226 · Cited by 15 · see citing works

Graphene Oxide/Zinc Oxide Nanocomposite Displaying Selective Toxicity to Glioblastoma Cell Lines

Jovito, B. L., Paterno, L. G., Sales, M. J. A., Gross, M. A., Silva, L. P., Souza, P. D., & Báo, S. N. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01369 · Cited by 15 · see citing works

Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy

Kazlauskas, A., Darinskas, A., Meškys, R., Tamašauskas, A., & Urbonavičius, J. (2019) · BMC Cancer · doi:10.1186/s12885-019-5409-7 · Cited by 14 · see citing works

Barriers to overcoming immunotherapy resistance in glioblastoma

Gillette, J. S., Wang, E. J., Dowd, R. S., & Toms, S. A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1175507 · Cited by 13 · see citing works

An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism

Luo, N., Lin, K., Cai, Y., Zhang, Z., Sui, X., Han, Z., Yuan, W., Xing, J., Gui, Z., Liu, G., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.021 · Cited by 13 · see citing works

A concise review of immunotherapy for glioblastoma

Sager, O., Dinçoğlan, F., Demiral, S., Uysal, B., Gamsız, H., Dırıcan, B., & Beyzadeoğlu, M. (2018) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2018.12 · Cited by 13 · see citing works

Clinicopathological associations and prognostic values of IDH1 gene mutation, MGMT gene promoter methylation, and PD-L1 expressions in high-grade glioma treated with standard treatment

July, J., Patricia, D., Gunawan, P. Y., Setiajaya, H., Ginting, T. E., Putra, T. P., Wuisan, Z. G., Budhiarko, D., Masykura, N., Prayogi, G., et al. (2020) · Pan African Medical Journal · doi:10.11604/pamj.2020.36.309.24831 · Cited by 13 · see citing works

Matrix Hyaluronic Acid and Hypoxia Influence a CD133 + Subset of Patient-Derived Glioblastoma Cells

Chen, J.-W. E., Leary, S. E. S., Barnhouse, V. R., Sarkaria, J. N., & Harley, B. A. C. (2021) · Tissue Engineering Part A · doi:10.1089/ten.tea.2021.0117 · Cited by 13 · see citing works

Repurposed Drugs in Treating Glioblastoma Multiforme: Clinical Trials Update

Yadavalli, S., Yenugonda, V. M., & Kesari, S. (2019) · The Cancer Journal · doi:10.1097/ppo.0000000000000365 · Cited by 13 · see citing works

Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study

Zhong, S., Wu, B., Yang, W., Ge, J., Zhang, X., Chen, Z., Duan, H., He, Z., Liu, Y., Wang, H., et al. (2021) · Aging · doi:10.18632/aging.103986 · Cited by 13 · see citing works

Inhibition of FAM83D displays antitumor effects in glioblastoma via down‐regulation of the AKT /Wnt/β‐catenin pathway

Wang, J., Quan, Y. H., Lv, J., Gong, S., & Ren, P. (2022) · Environmental Toxicology · doi:10.1002/tox.23488 · Cited by 13 · see citing works

Implantable Ultrasound‐Powered MXene/PVA Hydrogel‐Based Generator for Treatment of Glioblastoma

Hu, X., Qiu, Z., Yang, Y., Xu, T., Sheng, K., Lu, W., Xie, J., & Xu, B. (2024) · Advanced Science · doi:10.1002/advs.202309610 · Cited by 12 · see citing works

GLIOBLASTOMA MULTIFORME: A REVIEW OF ITS PATHOGENESIS AND TREATMENT

Banu, Z. (2019) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.0912283 · Cited by 12 · see citing works

Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells

Momeny, M., Shamsaiegahkani, S., Kashani, B., Hamzehlou, S., Esmaeili, F., Yousefi, H., Irani, S., Mousavi, S. A., & Ghaffari, S. H. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120100 · Cited by 12 · see citing works

The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis

Yan, W., & Wu, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.761693 · Cited by 12 · see citing works

Review: Neurological Complications From Therapies for Pediatric Brain Tumors

Nguyen, T. P., Mueller, S., & Malbari, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.853034 · Cited by 12 · see citing works

Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients

Viana‐Pereira, M., Moreno, D. A., Linhares, P., de Amorim, J. A., Nabiço, R., Costa, S., Vaz, R. M., & Reis, R. M. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05178-8 · Cited by 12 · see citing works

Current Therapeutic Strategies for Glioblastoma

Rossignol, J., Srinageshwar, B., & Dunbar, G. L. (2019) · Brain Sciences · doi:10.3390/brainsci10010015 · Cited by 12 · see citing works

Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents

Wang, W., Rodríguez-Silva, M., de la Rocha, A. A., Wolf, A. L., Lai, Y., Liu, Y., Reinhold, W. C., Pommier, Y. G., Chambers, J. W., & Tse‐Dinh, Y. (2019) · Cancers · doi:10.3390/cancers11101416 · Cited by 11 · see citing works

Cerebral organoids: emerging ex vivo humanoid models of glioblastoma

Papaioannou, M.-D., Sangster, K. T., Sajid, R. S., Djuric, U., & Diamandis, P. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01077-3 · Cited by 11 · see citing works

Does covid-19 impair endogenous neurogenesis?

Kumaria, A., Noah, M. A., & Kirkman, M. A. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.09.006 · Cited by 10 · see citing works

Molecular Investigation of Human Cytomegalovirus and Epstein-Barr virus in Glioblastoma Brain Tumor: A Case-Control Study in Iran

Ghaffari, H., dfgd, Tavakoli, A., dgdg, Faranoush, M., sdgf, Naderi, A., df, Kiani, S. J., dsfgdf, et al. (2021) · Iranian Biomedical Journal · doi:10.52547/ibj.25.6.426 · Cited by 10 · see citing works

RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway

Sun, Q., Xu, J., Yuan, F., Liu, Y., Chen, Q., Guo, L., Dong, H., & Liu, B. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2321770 · Cited by 9 · see citing works

The Evaluation of Glioblastoma Cell Dissociation and Its Influence on Its Behavior

Skarková, V., Krupova, M., Vítovcová, B., Skarka, A., Kašparová, P., Krůpa, P., Králová, V., & Rudolf, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184630 · Cited by 9 · see citing works

Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells—EGFRvIII Appears as a Weak Oncogene

Włodarczyk, A., Tręda, C., Rutkowska, A., Grot, D., Dobrewa, W., Kierasińska, A., Węgierska, M., Wasiak, T., Strózik, T., Rieske, P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012129 · Cited by 8 · see citing works

Neuronal Nitric Oxide Synthase in Cultured Cerebellar Bergmann Glia: Glutamate-Dependent Regulation

Tiburcio‐Félix, R., Cisneros, B., Hernández‐Kelly, L. C., Hernández-Contreras, M. A., Luna‐Herrera, J., Rea-Hernández, I., Jiménez-Aguilar, R., Olivares-Bañuelos, T. N., & Ortega, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00656 · Cited by 8 · see citing works

Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity

Finch, E., Duke, E. S., Hwang, E. I., & Packer, R. J. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.01.004 · Cited by 8 · see citing works

Impact of brain shift on neural pathways in deep brain stimulation: a preliminary analysis via multi-physics finite element models

Luo, M., Narasimhan, S., Larson, P., Martin, A. J., Konrad, P. E., & Miga, M. I. (2021) · Journal of Neural Engineering · doi:10.1088/1741-2552/abf066 · Cited by 9 · see citing works

Primary Extra-axial Glioblastoma: Case Report and Literature Review

Dabboucy, B., Younes, P., Rahbani, A., Fahed, E., & Abadjian, G. (2021) · Arquivos Brasileiros de Neurocirurgia Brazilian Neurosurgery · doi:10.1055/s-0041-1730373 · Cited by 7 · see citing works

IRAM–NET model: image residual agnostics meta-learning-based network for rare de novo glioblastoma diagnosis

Singh, K., & Malhotra, D. (2024) · Neural Computing and Applications · doi:10.1007/s00521-024-10347-3 · Cited by 7 · see citing works

Bridging the gap between tumor and disease: Innovating cancer and glioma models

Cirigliano, S. M., & Fine, H. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20220808 · Cited by 7 · see citing works

Exploring anticancer activity of structurally modified benzylphenoxyacetamide (BPA); I: Synthesis strategies and computational analyses of substituted BPA variants with high anti-glioblastoma potential

Stalińska, J., Houser, L., Rak, M., Colley, S. B., Krzysztof Reiss, F., & Jursic, B. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-53207-0 · Cited by 7 · see citing works

Cucurbitane triterpenoid entities derived from Hemsleya penxianensis triggered glioma cell apoptosis via ER stress and MAPK signalling cross-talk

Li, Z., Chen, M., Chen, F., Li, W., Huang, G., Xu, X., Wang, S., Ma, G., & Cui, P. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106013 · Cited by 7 · see citing works

Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients’ survival

Moreno, D. A., da Silva, L. S., Gomes, I., Leal, L. F., Berardinelli, G. N., Gonçalves, G. M., Pereira, C. A., Santana, I. V. V., Matsushita, M. D. M., Bhat, K., et al. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221127678 · Cited by 7 · see citing works

Letrozole targets the human ether‐a‐go‐go–related gene potassium current in glioblastoma

Shugg, T., Dave, N., Amarh, E., Assiri, A. A., Pollok, K. E., & Overholser, B. R. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13515 · Cited by 7 · see citing works

Hyperbaric oxygen promotes both the proliferation and chemosensitization of glioblastoma cells by inhibiting HIF1α/HIF2α-ABCG2

Gong, S., Wang, P., Liao, B., Zhao, L., & Wu, N. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1584407 · Cited by 6 · see citing works

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Hayashi, Y., Millen, J.-C. A., Ramos, R. I., Linehan, J., Wilson, T. G., Hoon, D. S. �., & Bustos, M. A. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13709 · Cited by 6 · see citing works

An overview of current therapeutic strategies for glioblastoma and the role of CD73 as an alternative curative approach

Arab, S., & Hasannejad, F. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02732-4 · Cited by 6 · see citing works

Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype

Steponaitis, G., Kucinskas, V., Golubickaitė, I., Skauminas, K., & Saudargienė, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415875 · Cited by 6 · see citing works

Mesoporous silica nanoparticles in glioblastoma: smart nano-platforms for targeted therapy and precision diagnosis

Hiremath, P., Naik, G. A. R. R., Roy, A. A., Kudarha, R. R., Rachana, S. P., Hedayat, P., Patel, J., Mutalik, S., Singh, A., & Dhas, N. L. (2026) · 3 Biotech · doi:10.1007/s13205-025-04639-1 · Cited by 6 · see citing works

Unlocking glioblastoma: breakthroughs in molecular mechanisms and next-generation therapies

Rizwani, F., Patil, P., & Jain, K. (2025) · Medical Oncology · doi:10.1007/s12032-025-02830-1 · Cited by 34 · see citing works

[Drug Therapy for Glioblastoma:Standard and Novel Treatments].

Otani, Y., Hirano, S., Ishida, J., & Tanaka, S. (2026) · PubMed · doi:10.11477/mf.030126030540040737

Frontiers in glioblastoma therapy: Novel therapeutics, molecular pathways, and future clinical perspectives

Pandey, S., Dwivedi, A., Singh, R., Habib, N., Kashyap, D., Saini, V., Singh, A., Sharma, A., & Jha, H. C. (2025) · Human Gene · doi:10.1016/j.humgen.2025.201507 · Cited by 5 · see citing works

Next-generation therapeutics for glioblastoma: Challenges and future directions

Blaquier, J. B., Lim-Fat, M. J., & de la Fuente, M. I. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e01050 · Cited by 1 · see citing works

Modern approaches to glioblastoma therapy

Kuznetsova, N. S., Гурова, С. В., Гончарова, А. С., Заикина, Е. В., Gusareva, M. A., & Сергеевич, З. М. (2023) · South Russian Journal of Cancer · doi:10.37748/2686-9039-2023-4-1-6 · Cited by 27 · see citing works